| M3R | Name: | Methyl phosphonated L-Arginine | Formula: | C7 H17 N4 O4 P | SMILES: | O=P(O)(NC(C(=O)O)CCCNC(=[N@H])N)C | InChi: | InChI=1S/C7H17N4O4P/c1-16(14,15)11-5(6(12)13)3-2-4-10-7(8)9/h5H,2-4H2,1H3,(H,12,13)(H4,8,9,10)(H2,11,14,15)/t5-/m0/s1 | Synonyms: | (2S)-5-carbamimidamido-2-[(hydroxy-methyl-phosphoryl)amino]pentanoic acid | Definition date: | 2009-03-20 | Last modified: | 2021-03-01 | Identifier: | N~2~-[(R)-hydroxy(methyl)phosphoryl]-L-arginine |
|
| B7A | Name: | 2'-deoxy-5-formyluridine 5'-(tetrahydrogen triphosphate) | Formula: | C10 H15 N2 O15 P3 | SMILES: | C2(COP(=O)(O)OP(O)(OP(=O)(O)O)=O)C(CC(N1C(NC(C(C=O)=C1)=O)=O)O2)O | InChi: | InChI=1S/C10H15N2O15P3/c13-3-5-2-12(10(16)11-9(5)15)8-1-6(14)7(25-8)4-24-29(20,21)27-30(22,23)26-28(17,18)19/h2-3,6-8,14H,1,4H2,(H,20,21)(H,22,23)(H,11,15,16)(H2,17,18,19)/t6-,7+,8+/m0/s1 | Synonyms: | 5-FodUTP | Definition date: | 2017-08-03 | Last modified: | 2021-03-01 | Release date: | 2017-09-13 | Identifier: | 2'-deoxy-5-formyluridine 5'-(tetrahydrogen triphosphate) |
|
| SNP | Name: | 1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL | Formula: | C16 H21 N O2 | SMILES: | OC(CNC(C)C)COc2cccc1ccccc12 | InChi: | InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3/t14-/m0/s1 | Synonyms: | S-PROPRANOLOL | Definition date: | 2000-01-26 | Last modified: | 2021-03-01 | Identifier: | (2S)-1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol |
|
| MYZ | Name: | Myristoleic acid | Formula: | C14 H26 O2 | SMILES: | O=C(O)CCCCCCCC=C/CCCC | InChi: | InChI=1S/C14H26O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h5-6H,2-4,7-13H2,1H3,(H,15,16)/b6-5- | Synonyms: | Z-tetradec-9-enoic acid | Definition date: | 2014-09-05 | Last modified: | 2021-03-01 | Release date: | 2015-02-25 | Identifier: | (9Z)-tetradec-9-enoic acid |
|
| CEI | Name: | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN-2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | Formula: | C25 H21 N3 O3 | SMILES: | O=C(Nc1ncc(nc1Cc2ccccc2)c3ccc(O)cc3)Cc4ccc(O)cc4 | InChi: | InChI=1S/C25H21N3O3/c29-20-10-6-18(7-11-20)15-24(31)28-25-22(14-17-4-2-1-3-5-17)27-23(16-26-25)19-8-12-21(30)13-9-19/h1-13,16,29-30H,14-15H2,(H,26,28,31) | Synonyms: | COELENTERAMIDE | Definition date: | 2004-01-26 | Last modified: | 2021-03-01 | Identifier: | N-[3-benzyl-5-(4-hydroxyphenyl)pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide |
|
| KYA | Name: | 4-hydroxyquinoline-2-carboxylic acid | Formula: | C10 H7 N O3 | SMILES: | O=C(O)c1nc2ccccc2c(O)c1 | InChi: | InChI=1S/C10H7NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-5H,(H,11,12)(H,13,14) | Synonyms: | Kynurenic acid | Definition date: | 2011-03-15 | Last modified: | 2021-03-01 | Identifier: | 4-hydroxyquinoline-2-carboxylic acid |
|
| CEN | Name: | 7BETA-(4CARBOXYBUTANAMIDO) CEPHALOSPORANIC ACID | Formula: | C15 H18 N2 O8 S | SMILES: | O=C2N1C(=C(CSC1C2NC(=O)CCCC(=O)O)COC(=O)C)C(=O)O | InChi: | InChI=1S/C15H18N2O8S/c1-7(18)25-5-8-6-26-14-11(13(22)17(14)12(8)15(23)24)16-9(19)3-2-4-10(20)21/h11,14H,2-6H2,1H3,(H,16,19)(H,20,21)(H,23,24)/t11-,14-/m1/s1 | Synonyms: | GLUTARYL 7-AMINO CEPHALOSPORANIC ACID | Definition date: | 2001-01-19 | Last modified: | 2021-03-01 | Identifier: | (6R,7R)-3-[(acetyloxy)methyl]-7-[(4-carboxybutanoyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|
| RFX | Name: | (3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine | Formula: | C17 H18 F3 N O | SMILES: | FC(F)(F)c2ccc(OC(c1ccccc1)CCNC)cc2 | InChi: | InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3/t16-/m1/s1 | Synonyms: | Fluoxetine | Definition date: | 2009-04-03 | Last modified: | 2021-03-01 | Identifier: | (3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine |
|
| Q8V | Name: | ethyl (2Z)-3-amino-2-cyano-3-phenylprop-2-enoate | Formula: | C12 H12 N2 O2 | SMILES: | c1cc(C(=C(C(OCC)=O)C#N)N)ccc1 | InChi: | InChI=1S/C12H12N2O2/c1-2-16-12(15)10(8-13)11(14)9-6-4-3-5-7-9/h3-7H,2,14H2,1H3/b11-10- | Synonyms: | phenamacril | Definition date: | 2019-10-03 | Last modified: | 2021-03-01 | Release date: | 2020-03-25 | Identifier: | ethyl (2Z)-3-amino-2-cyano-3-phenylprop-2-enoate |
|
| B7J | Name: | 2'-deoxy-5-formylcytidine 5'-(tetrahydrogen triphosphate) | Formula: | C10 H16 N3 O14 P3 | SMILES: | C2(COP(=O)(O)OP(O)(OP(O)(O)=O)=O)C(CC(N1C(N=C(C(C=O)=C1)N)=O)O2)O | InChi: | InChI=1S/C10H16N3O14P3/c11-9-5(3-14)2-13(10(16)12-9)8-1-6(15)7(25-8)4-24-29(20,21)27-30(22,23)26-28(17,18)19/h2-3,6-8,15H,1,4H2,(H,20,21)(H,22,23)(H2,11,12,16)(H2,17,18,19)/t6-,7+,8+/m0/s1 | Synonyms: | 5-FodCTP | Definition date: | 2017-08-03 | Last modified: | 2021-03-01 | Release date: | 2017-09-13 | Identifier: | 2'-deoxy-5-formylcytidine 5'-(tetrahydrogen triphosphate) |
|
| SNY | Name: | (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enal | Formula: | C11 H12 O4 | SMILES: | O=CC=Cc1cc(OC)c(O)c(OC)c1 | InChi: | InChI=1S/C11H12O4/c1-14-9-6-8(4-3-5-12)7-10(15-2)11(9)13/h3-7,13H,1-2H3/b4-3+ | Synonyms: | Sinapaldehyde | Definition date: | 2010-10-25 | Last modified: | 2021-03-01 | Identifier: | (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enal |
|
| LC2 | Name: | N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-2-yl]-2-oxopropanamide | Formula: | C25 H33 N O7 | SMILES: | O=C(C(=O)NC2C=C(C=CC(O)CC=C(C=CC(O)CC1OC(=O)C2(C(=O)C1C)C)C)C)C | InChi: | InChI=1S/C25H33NO7/c1-14-6-9-18(28)10-8-15(2)12-21(26-23(31)17(4)27)25(5)22(30)16(3)20(33-24(25)32)13-19(29)11-7-14/h6-8,10-12,16,18-21,28-29H,9,13H2,1-5H3,(H,26,31)/b10-8+,11-7+,14-6+,15-12+/t16-,18+,19-,20-,21-,25+/m1/s1 | Synonyms: | Lankacidin C | Definition date: | 2009-09-09 | Last modified: | 2021-03-01 | Identifier: | N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-2-yl]-2-oxopropanamide |
|
| SO1 | Name: | [1R-(1.ALPHA.,3A.BETA.,4.BETA.,4A.BETA.,7.BETA.,7A.ALPHA.,8A.BETA.)]8A-[(6-DEOXY-4-O-METHYL-BETA-D-ALTROPYRANOSYLOXY)METHYL]-4-FORMYL-4,4A,5,6,7,7A,8,8A-OCTAHYDRO-7-METHYL-3-(1-METHYLETHYL)-1,4-METHANO-S-INDACENE-3A(1H)-CARBOXYLIC ACID | Formula: | C27 H42 O8 | SMILES: | O=C(O)C53C4(COC1OC(C(OC)C(O)C1O)C)CC2C(C)CCC2C3(C=O)CC4CC5C(C)C | InChi: | InChI=1S/C27H42O8/c1-13(2)19-8-16-9-25(11-28)18-7-6-14(3)17(18)10-26(16,27(19,25)24(31)32)12-34-23-21(30)20(29)22(33-5)15(4)35-23/h11,13-23,29-30H,6-10,12H2,1-5H3,(H,31,32)/t14-,15-,16+,17-,18-,19?,20+,21+,22-,23-,25+,26+,27+/m1/s1 | Synonyms: | SORDARIN | Definition date: | 2003-01-20 | Last modified: | 2021-03-01 | Identifier: | (1S,3R,3aR,4S,4aR,7R,7aR,8aS)-8a-{[(6-deoxy-4-O-methyl-beta-D-altropyranosyl)oxy]methyl}-4-formyl-7-methyl-3-(1-methylethyl)decahydro-1,4-methano-s-indacene-3a(1H)-carboxylic acid |
|
| PGM | Name: | 1-MYRISTOYL-2-HYDROXY-SN-GLYCERO-3-[PHOSPHO-RAC-(1-GLYCEROL)] | Formula: | C22 H44 O9 P | SMILES: | O=C(OCC(O)COP([O-])(=O)OCC(O)CO)CCCCCCCCCCCCCCC | InChi: | InChI=1S/C22H45O9P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-22(26)29-17-21(25)19-31-32(27,28)30-18-20(24)16-23/h20-21,23-25H,2-19H2,1H3,(H,27,28)/p-1/t20-,21-/m0/s1 | Synonyms: | LYSOPHOSPHATIDYLGLYCEROL | Definition date: | 2002-12-12 | Last modified: | 2021-03-01 | Identifier: | (2S)-2,3-dihydroxypropyl (2S)-3-(hexadecanoyloxy)-2-hydroxypropyl phosphate |
|
| B7P | Name: | 2'-deoxy-5-fluorouridine 5'-(tetrahydrogen triphosphate) | Formula: | C9 H14 F N2 O14 P3 | SMILES: | C1=C(F)C(=O)NC(N1C2CC(O)C(O2)COP(=O)(O)OP(O)(OP(=O)(O)O)=O)=O | InChi: | InChI=1S/C9H14FN2O14P3/c10-4-2-12(9(15)11-8(4)14)7-1-5(13)6(24-7)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h2,5-7,13H,1,3H2,(H,19,20)(H,21,22)(H,11,14,15)(H2,16,17,18)/t5-,6+,7+/m0/s1 | Synonyms: | 5-FdUTP | Definition date: | 2017-08-03 | Last modified: | 2021-03-01 | Release date: | 2017-09-13 | Identifier: | 2'-deoxy-5-fluorouridine 5'-(tetrahydrogen triphosphate) |
|
| QO4 | Name: | 5-{[(2S)-1-(3-oxo-3-{4-[5-(trifluoromethyl)pyrimidin-2-yl]piperazin-1-yl}propoxy)propan-2-yl]amino}-4-(trifluoromethyl)pyridazin-3(2H)-one | Formula: | C20 H23 F6 N7 O3 | SMILES: | C(CC(=O)N1CCN(CC1)c2ncc(C(F)(F)F)cn2)OCC(C)NC3=C(C(=O)NN=C3)C(F)(F)F | InChi: | InChI=1S/C20H23F6N7O3/c1-12(30-14-10-29-31-17(35)16(14)20(24,25)26)11-36-7-2-15(34)32-3-5-33(6-4-32)18-27-8-13(9-28-18)19(21,22)23/h8-10,12H,2-7,11H2,1H3,(H2,30,31,35)/t12-/m0/s1 | Synonyms: | RBN-2397 | Definition date: | 2019-11-27 | Last modified: | 2021-03-01 | Release date: | 2020-12-16 | Identifier: | 5-{[(2S)-1-(3-oxo-3-{4-[5-(trifluoromethyl)pyrimidin-2-yl]piperazin-1-yl}propoxy)propan-2-yl]amino}-4-(trifluoromethyl)pyridazin-3(2H)-one |
|
| M4M | Name: | 1-amino-9,10-dioxo-4-[(4-sulfamoylphenyl)amino]-9,10-dihydroanthracene-2-sulfonic acid | Formula: | C20 H15 N3 O7 S2 | SMILES: | O=S(=O)(N)c1ccc(cc1)Nc4c3C(=O)c2ccccc2C(=O)c3c(c(c4)S(=O)(=O)O)N | InChi: | InChI=1S/C20H15N3O7S2/c21-18-15(32(28,29)30)9-14(23-10-5-7-11(8-6-10)31(22,26)27)16-17(18)20(25)13-4-2-1-3-12(13)19(16)24/h1-9,23H,21H2,(H2,22,26,27)(H,28,29,30) | Synonyms: | 1-amino-4-(4-aminosulfonyl)phenylamino-anthraquinone-2-sulfonic acid | Definition date: | 2011-10-06 | Last modified: | 2021-03-01 | Identifier: | 1-amino-9,10-dioxo-4-[(4-sulfamoylphenyl)amino]-9,10-dihydroanthracene-2-sulfonic acid |
|
| MZM | Name: | N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide | Formula: | C5 H8 N4 O3 S2 | SMILES: | NS(=O)(=O)C=1S/C(N(N=1)C)=NC(=O)C | InChi: | InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12)/b7-4- | Synonyms: | Methazolamide | Definition date: | 1999-07-08 | Last modified: | 2021-03-01 | Identifier: | N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide |
|
| PGX | Name: | 7-[6-(3-HYDROPEROXY-OCT-1-ENYL)-2,3-DIOXA-BICYCLO[2.2.1]HEPT-5-YL]-HEPT-5-ENOIC ACID | Formula: | C20 H32 O6 | SMILES: | O=C(O)CCC/C=CCC2C1OOC(C1)C2/C=C/C(OO)CCCCC | InChi: | InChI=1S/C20H32O6/c1-2-3-6-9-15(24-23)12-13-17-16(18-14-19(17)26-25-18)10-7-4-5-8-11-20(21)22/h4,7,12-13,15-19,23H,2-3,5-6,8-11,14H2,1H3,(H,21,22)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1 | Synonyms: | PROSTAGLANDIN G2 | Definition date: | 1999-11-10 | Last modified: | 2021-03-01 | Identifier: | (5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroperoxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]hept-5-yl}hept-5-enoic acid |
|
| TI3 | Name: | [(2S)-2-SULFANYL-3-PHENYLPROPANOYL]-GLY-(5-PHENYLPROLINE) | Formula: | C22 H24 N2 O4 S | SMILES: | O=C(N2C(C(=O)O)CCC2c1ccccc1)CNC(=O)C(S)Cc3ccccc3 | InChi: | InChI=1S/C22H24N2O4S/c25-20(14-23-21(26)19(29)13-15-7-3-1-4-8-15)24-17(11-12-18(24)22(27)28)16-9-5-2-6-10-16/h1-10,17-19,29H,11-14H2,(H,23,26)(H,27,28)/t17-,18+,19+/m1/s1 | Synonyms: | RB106 | Definition date: | 1999-07-08 | Last modified: | 2021-03-01 | Identifier: | N-[(2S)-3-phenyl-2-sulfanylpropanoyl]glycyl-(5R)-5-phenyl-L-proline |
|
| M4O | Name: | (2R)-3-{[(S)-{[(2R,3R,4R,5S,6S)-3-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2R,3R,4S,5R,6S)-6-carbamoyl-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl]oxy}-6-carbamoyl-4-(carbamoyloxy)-5-hydroxy-5-methyltetrahydro-2H-pyran-2-yl]oxy}(hydroxy)phosphoryl]oxy}-2-{[(2Z)-3,7-dimethylocta-2,6-dien-1-yl]oxy}propanoic acid | Formula: | C49 H80 N5 O32 P | SMILES: | O=C(O)C(OC/C=C(/C)CCC=C(/C)C)COP(=O)(O)OC5OC(C(=O)N)C(O)(C)C(OC(=O)N)C5OC4OC(COC1OC(C(O)C(O)C1O)CO)C(OC3OC(C)C(OC2OC(C(=O)N)C(O)C(O)C2O)C(O)C3NC(=O)C)C(O)C4NC(=O)C | InChi: | InChI=1S/C49H80N5O32P/c1-16(2)9-8-10-17(3)11-12-74-23(42(68)69)15-76-87(72,73)86-47-37(38(85-48(52)70)49(7,71)39(84-47)41(51)67)83-44-25(54-20(6)57)28(60)35(22(79-44)14-75-45-32(64)29(61)26(58)21(13-55)78-45)81-43-24(53-19(5)56)27(59)34(18(4)77-43)80-46-33(65)30(62)31(63)36(82-46)40(50)66/h9,11,18,21-39,43-47,55,58-65,71H,8,10,12-15H2,1-7H3,(H2,50,66)(H2,51,67)(H2,52,70)(H,53,56)(H,54,57)(H,68,69)(H,72,73)/b17-11-/t18-,21-,22-,23-,24-,25-,26-,27-,28-,29+,30+,31-,32-,33-,34-,35-,36+,37-,38-,39-,43+,44+,45-,46-,47-,49+/m1/s1 | Synonyms: | Neryl Moenomycin A | Definition date: | 2008-02-28 | Last modified: | 2021-03-01 | Identifier: | (2R)-3-{[(S)-{[(2R,3R,4R,5S,6S)-3-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2R,3R,4S,5R,6S)-6-carbamoyl-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl]oxy}-6-carbamoyl-4-(carbamoyloxy)-5-hydroxy-5-methyltetrahydro-2H-pyran-2-yl]oxy}(hydroxy)phosphoryl]oxy}-2-{[(2Z)-3,7-dimethylocta-2,6-dien-1-yl]oxy}propanoic acid (non-preferred name) |
|
| B81 | Name: | (3alpha,8alpha,17beta)-androst-5-ene-3,17-diol | Formula: | C19 H30 O2 | SMILES: | OC4CCC1(C(=CCC2C1CCC3(C2CCC3O)C)C4)C | InChi: | InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-17,20-21H,4-11H2,1-2H3/t13-,14-,15-,16-,17-,18-,19-/m0/s1 | Synonyms: | 5-Androstenediol | Definition date: | 2009-07-29 | Last modified: | 2021-03-01 | Identifier: | (3alpha,8alpha,17beta)-androst-5-ene-3,17-diol |
|
| PH1 | Name: | 1,2-[DI-2,6,10,14-TETRAMETHYL-HEXADECAN-16-OXY]-PROPANE | Formula: | C43 H88 O2 | SMILES: | O(CCC(C)CCCC(C)CCCC(C)CCCC(C)C)CC(OCCC(CCCC(CCCC(C)CCCC(C)C)C)C)C | InChi: | InChI=1S/C43H88O2/c1-35(2)18-12-20-37(5)22-14-24-39(7)26-16-28-41(9)30-32-44-34-43(11)45-33-31-42(10)29-17-27-40(8)25-15-23-38(6)21-13-19-36(3)4/h35-43H,12-34H2,1-11H3/t37-,38-,39-,40-,41-,42-,43+/m0/s1 | Synonyms: | PHYTANYL MOIETY | Definition date: | 1999-07-08 | Last modified: | 2021-03-01 | Identifier: | (3S,7S,11S,3'S,7'S,11'S)-1,1'-[(2R)-propane-1,2-diylbis(oxy)]bis(3,7,11,15-tetramethylhexadecane) |
|
| LCL | Name: | 2,2-dichloro-N-[(1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide | Formula: | C11 H12 Cl2 N2 O5 | SMILES: | O=[N+]([O-])c1ccc(cc1)C(O)C(NC(=O)C(Cl)Cl)CO | InChi: | InChI=1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m0/s1 | Synonyms: | L-Chloramphenicol | Definition date: | 2012-08-16 | Last modified: | 2021-03-01 | Release date: | 2013-05-08 | Identifier: | 2,2-dichloro-N-[(1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide |
|
| B82 | Name: | 2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid | Formula: | C18 H19 Br N2 O5 S | SMILES: | CCN(CC)[S](=O)(=O)c1cc(ccc1Br)C(=O)Nc2ccccc2C(O)=O | InChi: | InChI=1S/C18H19BrN2O5S/c1-3-21(4-2)27(25,26)16-11-12(9-10-14(16)19)17(22)20-15-8-6-5-7-13(15)18(23)24/h5-11H,3-4H2,1-2H3,(H,20,22)(H,23,24) | Synonyms: | 2-({4-bromo-3-[(diethylamino)sulfonyl]benzoyl}amino)benzoic acid | Definition date: | 2009-08-10 | Last modified: | 2021-03-01 | Identifier: | 2-[[4-bromo-3-(diethylsulfamoyl)phenyl]carbonylamino]benzoic acid |
|